Sana Biotechnology, Inc. (SANA) Stock Analysis — Probabli.AI
AI-powered analysis for SANA (Sana Biotechnology, Inc.): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. Latest AI outlook: Bullish.
Last price: $3.20 · Market cap: $1.1B · AI outlook: Bullish
Sana Biotechnology shows strong potential given its field-leading innovations in regenerative medicine, despite risks like regulatory challenges and high operating expenses. Its robust pipeline and positive early stage trial results suggest it could outpace traditional market returns, making it a compelling candidate for long-term growth investment.
Probabilistic 1-Year Outlook
- Bull 40% · Neutral 30% · Bear 30%
- 1-year price estimates — P10: $3 / P50: $5 / P90: $8
- Sana Biotechnology has robust pipeline development, investor interest, and recent positive trial data, although FDA hurdles introduce risk.
5-Year Outlook
- Bull 60% · Neutral 25% · Bear 15%
- 5-year price estimates — P10: $3 / P50: $10 / P90: $25
SWOT Highlights
- Strength: Innovative cell and gene therapy pipeline
- Strength: Strong partnerships with major pharmaceutical companies
- Risk: High cash burn rate typical of biotechnology startups
- Risk: Dependence on successful approval of trials
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
6 Wall Street analysts rate SANA a BUY with a mean price target of $7.5.
Last analyzed · Model: gpt-4o. How this forecast works · Accuracy & validation.
SANA forecast details · SANA sentiment details · SANA insider activity
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.